METS-IR demonstrates significant associations with pre-diabetes [32], DM [33], CVD [34], stroke [35], and hyperuricemia [10], outperforming other non-insulin-based IR surrogates in differential diagnosis [8]. The gene discussed is INS; the disease is stroke disorder.